Cambrex is an innovative life sciences company that provides pharmaceutical products, expertise and technologies that accelerate small molecule therapeutics into markets across the world.

Central Glass Germany is dedicated to process development, upscaling and production of active ingredients and intermediates for the pharmaceutical and cosmetics industry. It operates a FDA and EU inspected facility in Halle-Künsebeck, which it acquired from Girindus in June 2008. An experienced and highly skilled team of organic read morechemists and support functions, such as analytical specialists and QA/QC team, ensure success and high quality of our projects.